Takeda Pharmaceuticals Korea released DPP-4 inhibitor, Nesina tablet for diabetes treatment in the d

Published: 2014-01-08 06:57:00

Updated: 2014-01-08 06:57:00

Takeda Pharmaceuticals Korea released DPP-4 inhibitor, Nesina tablet for diabetes treatment in the domestic market.
(Yakup Shinmoon)

On Jan 3, Takeda Pharmaceuticals Korea announced that they released Nesina tablet (ingredient: alogliptin benzoate) for type 2 diabetes treatment in the domestic market.

Nesina tablet is a DPP-4 inhibitor for the treatment of type 2 diabetes, and it is ab...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.